Almonty Industries: Wolfram Producer’s Two-Front Transition Leaves Investors Wrestling With Conflicting Signals

The tungsten producer Almonty Industries is navigating one of the most consequential stretches in its corporate history, yet the market’s verdict on the stock has been decidedly harsh. While the company’s flagship Sangdong mine in South Korea has finally shifted into active production after years of development, management is simultaneously dismantling its presence on two major stock exchanges. The result is a share price caught in a violent tug-of-war between operational promise and structural upheaval.

A Streamlined Listing Strategy Takes Shape

The most immediate catalyst for investor anxiety is the company’s accelerating retreat from its traditional trading venues. Almonty has now formally initiated its exit from both the Toronto Stock Exchange and the Australian Securities Exchange, a two-step process that will leave the Nasdaq and Frankfurt as its sole listing venues. The Australian leg of the withdrawal has received official approval from the local regulator, with trading in CDI entitlements scheduled to conclude on August 28. The formal delisting takes effect on September 1, 2026.

Australian shareholders face a clear deadline with two paths forward: they can liquidate their positions on the ASX before the cutoff, or convert their holdings into Nasdaq-listed shares on a 1:1 basis. Those who hold positions after the delisting will have access to a voluntary sell-down facility running from September 8 through November 6, 2026. The Toronto departure, meanwhile, was completed on July 31, 2026.

Management’s rationale for the dual exit is straightforward: trading volumes on the ASX and TSX had dwindled to levels that no longer justified the associated administrative and compliance overhead. With liquidity concentrated on the Nasdaq, the company sees little reason to maintain costly secondary listings that attract minimal activity.

Sangdong Delivers, But the Chart Tells Another Story

The operational side of the business offers a starkly different narrative. Almonty’s processing facility at Sangdong began throughput operations on July 1, following the start of ore processing from stockpiles in June. The company has poured more than $100 million into the project, which now holds roughly 139,700 tonnes of ore at a WO3 grade of 0.25 percent — representing an estimated value of $68 million and sufficient feed for approximately 2.6 months of processing.

The longer-term fundamentals are even more compelling on paper. Sangdong boasts an expected mine life exceeding 45 years, with an average grade of 0.51 percent — roughly three times the global average, according to company figures. At full production capacity, the mine is positioned to satisfy around 40 percent of tungsten demand outside China. CEO Lewis Black framed the production start as a strategic milestone, noting that the Western tungsten supply chain had contracted over decades and that Sangdong now represents a renewed source of critical metal.

The market, however, has yet to reward these developments. The stock closed Friday at C$15.88, down 2.70 percent on the day and 15.58 percent lower over the past seven trading sessions. The 30-day decline is steeper still at 28.63 percent. Yet context matters: the shares remain up 31.57 percent since the start of the year, and the current price sits 52.38 percent below the 52-week high of C$33.35, reached on April 17. For additional perspective, the stock traded at just C$4.96 on July 31, 2025 — a reminder of how far the equity has traveled in a relatively short window.

Should investors sell immediately? Or is it worth buying Almonty?

Technical Damage and Valuation Questions

The recent slide has pushed the stock decisively below key technical levels. The share price now trades 31.01 percent under its 50-day moving average of C$23.02, while the 14-day relative strength index of 33.5 suggests the equity is approaching oversold territory. With annualized volatility hovering near 89 percent, the market is clearly pricing in substantial uncertainty.

Valuation models add another layer of contention. One commonly cited fair-value framework pegs the stock’s intrinsic worth at just $1.12, implying an overvaluation of 887.5 percent relative to the Nasdaq price. The underlying valuation score stands at 53 out of 100, with a forward price-to-earnings ratio of 28.4. Almonty remains unprofitable and cash-flow negative, and no insider transactions have been recorded over the past three months.

A Contract Milestone Complements the Production Ramp

Amid the market turbulence, Almonty has also strengthened its commercial foundation. In early July, the company announced an expanded supply agreement with Global Tungsten & Powders, a partnership dating back to 2018. The revised deal extends the contract term by six years, stretching from 15 to 21 years from initial delivery, while increasing contracted volumes by 40 percent and improving pricing by approximately 6.3 percent. The company expects annual contract revenue to rise by at least $30 million, with total revenues over the 21-year term projected at $490 million from this single agreement alone.

The contract covers roughly 90 percent of phase-one tungsten concentrate production from Sangdong, effectively locking in demand for the mine’s near-term output. The timing aligns neatly with the facility’s transition from construction into active production — a shift that should, in theory, begin converting operational milestones into actual revenue.

Two Divergent Stories, One Stock

Investors are left weighing two fundamentally different narratives. On one side sits a company that has spent years preparing Sangdong for production, secured a major offtake partner, and now commands a mine with decades of expected life and grades well above industry norms. On the other sits a stock that has shed more than half its value from its peak, faces persistent questions about valuation, and is in the midst of a listing consolidation that narrows trading access for existing shareholders.

The coming weeks will bring further clarity on the structural front as the ASX exit completes and trading volume concentrates on the Nasdaq. The more consequential test, however, lies ahead: whether Sangdong can reach full phase-one capacity and deliver the kind of financial results that justify the operational narrative — and the stock’s remaining premium.